mRNA Vaccines Now Headed for Shrimp - Dr Mercola
https://articles.mercola.com/sites/articles/archive/2023/09/14/shrimp-mrna-vaccine.aspx?ui=551eda515442ee5cc8f0c77cc67b3f3febd63142ec0dc6cef1d4521e5ea666eb&sd=20200307&cid_source=dnl&cid_medium=email&cid_content=art1ReadMore&cid=20230914&foDate=false&mid=DM1463565&rid=1911282616
Story at-a-glance
ViAqua Therapeutics, an Israeli-based biotechnology startup, has secured $8.25 million in funding for its oral RNA-based shrimp vaccine
The vaccine targets white spot syndrome virus (WSSV), which leads to a 15% reduction in global shrimp production each year
ViAqua plans to administer its RNA-based product via coated feed; the RNA molecules can inhibit gene expression, silencing disease-affected ge
https://articles.mercola.com/sites/articles/archive/2023/09/14/shrimp-mrna-vaccine.aspx?ui=551eda515442ee5cc8f0c77cc67b3f3febd63142ec0dc6cef1d4521e5ea666eb&sd=20200307&cid_source=dnl&cid_medium=email&cid_content=art1ReadMore&cid=20230914&foDate=false&mid=DM1463565&rid=1911282616
Story at-a-glance
ViAqua Therapeutics, an Israeli-based biotechnology startup, has secured $8.25 million in funding for its oral RNA-based shrimp vaccine
The vaccine targets white spot syndrome virus (WSSV), which leads to a 15% reduction in global shrimp production each year
ViAqua plans to administer its RNA-based product via coated feed; the RNA molecules can inhibit gene expression, silencing disease-affected ge
mRNA Vaccines Now Headed for Shrimp - Dr Mercola
https://articles.mercola.com/sites/articles/archive/2023/09/14/shrimp-mrna-vaccine.aspx?ui=551eda515442ee5cc8f0c77cc67b3f3febd63142ec0dc6cef1d4521e5ea666eb&sd=20200307&cid_source=dnl&cid_medium=email&cid_content=art1ReadMore&cid=20230914&foDate=false&mid=DM1463565&rid=1911282616
Story at-a-glance
ViAqua Therapeutics, an Israeli-based biotechnology startup, has secured $8.25 million in funding for its oral RNA-based shrimp vaccine
The vaccine targets white spot syndrome virus (WSSV), which leads to a 15% reduction in global shrimp production each year
ViAqua plans to administer its RNA-based product via coated feed; the RNA molecules can inhibit gene expression, silencing disease-affected ge
0 Comments
0 Shares
2621 Views